RIO DE JANEIRO, BRAZIL – Brazil will start its last testing stage for one of many coronavirus vaccines on July 20th. The Nationwide Well being Surveillance Company (ANVISA), the Brazilian authority on medication regulation, licensed the beginning of trials by the Butantan Institute in São Paulo, a companion of Chinese language pharmaceutical firm Sinovac Biotech since final month.
With 1.6 million instances and virtually 65,000 deaths from the illness, Brazil has come below worldwide corporations’ radar as a volunteer middle for the trials, which require a location the place the virus circulation continues to be excessive. Along with becoming a member of the Chinese language . . .